Literature DB >> 23407457

Quantitative high-throughput single-cell cytotoxicity assay for T cells.

Ivan Liadi1, Jason Roszik, Gabrielle Romain, Laurence J N Cooper, Navin Varadarajan.   

Abstract

Cancer immunotherapy can harness the specificity of immune response to target and eliminate tumors. Adoptive cell therapy (ACT) based on the adoptive transfer of T cells genetically modified to express a chimeric antigen receptor (CAR) has shown considerable promise in clinical trials(1-4). There are several advantages to using CAR(+) T cells for the treatment of cancers including the ability to target non-MHC restricted antigens and to functionalize the T cells for optimal survival, homing and persistence within the host; and finally to induce apoptosis of CAR(+) T cells in the event of host toxicity(5). Delineating the optimal functions of CAR(+) T cells associated with clinical benefit is essential for designing the next generation of clinical trials. Recent advances in live animal imaging like multiphoton microscopy have revolutionized the study of immune cell function in vivo(6,7). While these studies have advanced our understanding of T-cell functions in vivo, T-cell based ACT in clinical trials requires the need to link molecular and functional features of T-cell preparations pre-infusion with clinical efficacy post-infusion, by utilizing in vitro assays monitoring T-cell functions like, cytotoxicity and cytokine secretion. Standard flow-cytometry based assays have been developed that determine the overall functioning of populations of T cells at the single-cell level but these are not suitable for monitoring conjugate formation and lifetimes or the ability of the same cell to kill multiple targets(8). Microfabricated arrays designed in biocompatible polymers like polydimethylsiloxane (PDMS) are a particularly attractive method to spatially confine effectors and targets in small volumes(9). In combination with automated time-lapse fluorescence microscopy, thousands of effector-target interactions can be monitored simultaneously by imaging individual wells of a nanowell array. We present here a high-throughput methodology for monitoring T-cell mediated cytotoxicity at the single-cell level that can be broadly applied to studying the cytolytic functionality of T cells.

Entities:  

Mesh:

Year:  2013        PMID: 23407457      PMCID: PMC3596999          DOI: 10.3791/50058

Source DB:  PubMed          Journal:  J Vis Exp        ISSN: 1940-087X            Impact factor:   1.355


  14 in total

1.  Rapid, efficient functional characterization and recovery of HIV-specific human CD8+ T cells using microengraving.

Authors:  Navin Varadarajan; Douglas S Kwon; Kenneth M Law; Adebola O Ogunniyi; Melis N Anahtar; James M Richter; Bruce D Walker; J Christopher Love
Journal:  Proc Natl Acad Sci U S A       Date:  2012-02-21       Impact factor: 11.205

Review 2.  Living in a house of cards: re-evaluating CD8+ T-cell immune correlates against HIV.

Authors:  George Makedonas; Michael R Betts
Journal:  Immunol Rev       Date:  2011-01       Impact factor: 12.988

3.  Chimeric antigen receptor-modified T cells in chronic lymphoid leukemia.

Authors:  David L Porter; Bruce L Levine; Michael Kalos; Adam Bagg; Carl H June
Journal:  N Engl J Med       Date:  2011-08-10       Impact factor: 91.245

4.  T cells with chimeric antigen receptors have potent antitumor effects and can establish memory in patients with advanced leukemia.

Authors:  Michael Kalos; Bruce L Levine; David L Porter; Sharyn Katz; Stephan A Grupp; Adam Bagg; Carl H June
Journal:  Sci Transl Med       Date:  2011-08-10       Impact factor: 17.956

5.  Antitumor activity and long-term fate of chimeric antigen receptor-positive T cells in patients with neuroblastoma.

Authors:  Chrystal U Louis; Barbara Savoldo; Gianpietro Dotti; Martin Pule; Eric Yvon; G Doug Myers; Claudia Rossig; Heidi V Russell; Oumar Diouf; Enli Liu; Hao Liu; Meng-Fen Wu; Adrian P Gee; Zhuyong Mei; Cliona M Rooney; Helen E Heslop; Malcolm K Brenner
Journal:  Blood       Date:  2011-10-07       Impact factor: 22.113

Review 6.  Adoptive immunotherapy for cancer: harnessing the T cell response.

Authors:  Nicholas P Restifo; Mark E Dudley; Steven A Rosenberg
Journal:  Nat Rev Immunol       Date:  2012-03-22       Impact factor: 53.106

7.  A high-throughput single-cell analysis of human CD8⁺ T cell functions reveals discordance for cytokine secretion and cytolysis.

Authors:  Navin Varadarajan; Boris Julg; Yvonne J Yamanaka; Huabiao Chen; Adebola O Ogunniyi; Elizabeth McAndrew; Lindsay C Porter; Alicja Piechocka-Trocha; Brenna J Hill; Daniel C Douek; Florencia Pereyra; Bruce D Walker; J Christopher Love
Journal:  J Clin Invest       Date:  2011-10-03       Impact factor: 14.808

8.  CD28 costimulation improves expansion and persistence of chimeric antigen receptor-modified T cells in lymphoma patients.

Authors:  Barbara Savoldo; Carlos Almeida Ramos; Enli Liu; Martha P Mims; Michael J Keating; George Carrum; Rammurti T Kamble; Catherine M Bollard; Adrian P Gee; Zhuyong Mei; Hao Liu; Bambi Grilley; Cliona M Rooney; Helen E Heslop; Malcolm K Brenner; Gianpietro Dotti
Journal:  J Clin Invest       Date:  2011-04-11       Impact factor: 14.808

9.  The role of IFN-gamma Elispot assay in HIV vaccine research.

Authors:  Hendrik Streeck; Nicole Frahm; Bruce D Walker
Journal:  Nat Protoc       Date:  2009       Impact factor: 13.491

10.  Screening individual hybridomas by microengraving to discover monoclonal antibodies.

Authors:  Adebola O Ogunniyi; Craig M Story; Eliseo Papa; Eduardo Guillen; J Christopher Love
Journal:  Nat Protoc       Date:  2009       Impact factor: 13.491

View more
  14 in total

1.  Automated profiling of individual cell-cell interactions from high-throughput time-lapse imaging microscopy in nanowell grids (TIMING).

Authors:  Amine Merouane; Nicolas Rey-Villamizar; Yanbin Lu; Ivan Liadi; Gabrielle Romain; Jennifer Lu; Harjeet Singh; Laurence J N Cooper; Navin Varadarajan; Badrinath Roysam
Journal:  Bioinformatics       Date:  2015-06-09       Impact factor: 6.937

2.  Antibody Fc engineering improves frequency and promotes kinetic boosting of serial killing mediated by NK cells.

Authors:  Gabrielle Romain; Vladimir Senyukov; Nicolas Rey-Villamizar; Amine Merouane; William Kelton; Ivan Liadi; Ankit Mahendra; Wissam Charab; George Georgiou; Badrinath Roysam; Dean A Lee; Navin Varadarajan
Journal:  Blood       Date:  2014-09-16       Impact factor: 22.113

3.  Multifaceted Role of BTLA in the Control of CD8+ T-cell Fate after Antigen Encounter.

Authors:  Krit Ritthipichai; Cara L Haymaker; Melisa Martinez; Andrew Aschenbrenner; Xiaohui Yi; Minying Zhang; Charuta Kale; Luis M Vence; Jason Roszik; Yared Hailemichael; Willem W Overwijk; Navin Varadarajan; Roza Nurieva; Laszlo G Radvanyi; Patrick Hwu; Chantale Bernatchez
Journal:  Clin Cancer Res       Date:  2017-07-28       Impact factor: 12.531

4.  Defining potency of CAR+ T cells: Fast and furious or slow and steady.

Authors:  Ivan Liadi; Harjeet Singh; Gabrielle Romain; Badrinath Roysam; Laurence Jn Cooper; Navin Varadarajan
Journal:  Oncoimmunology       Date:  2018-05-07       Impact factor: 8.110

Review 5.  Driving CAR-based T-cell therapy to success.

Authors:  Bipulendu Jena; Judy S Moyes; Helen Huls; Laurence J N Cooper
Journal:  Curr Hematol Malig Rep       Date:  2014-03       Impact factor: 3.952

6.  IgG Fc domains that bind C1q but not effector Fcγ receptors delineate the importance of complement-mediated effector functions.

Authors:  Chang-Han Lee; Gabrielle Romain; Wupeng Yan; Makiko Watanabe; Wissam Charab; Biliana Todorova; Jiwon Lee; Kendra Triplett; Moses Donkor; Oana I Lungu; Anja Lux; Nicholas Marshall; Margaret A Lindorfer; Odile Richard-Le Goff; Bianca Balbino; Tae Hyun Kang; Hidetaka Tanno; George Delidakis; Corrine Alford; Ronald P Taylor; Falk Nimmerjahn; Navin Varadarajan; Pierre Bruhns; Yan Jessie Zhang; George Georgiou
Journal:  Nat Immunol       Date:  2017-06-12       Impact factor: 25.606

7.  Individual Motile CD4(+) T Cells Can Participate in Efficient Multikilling through Conjugation to Multiple Tumor Cells.

Authors:  Ivan Liadi; Harjeet Singh; Gabrielle Romain; Nicolas Rey-Villamizar; Amine Merouane; Jay R T Adolacion; Partow Kebriaei; Helen Huls; Peng Qiu; Badrinath Roysam; Laurence J N Cooper; Navin Varadarajan
Journal:  Cancer Immunol Res       Date:  2015-02-24       Impact factor: 11.151

Review 8.  A new approach to gene therapy using Sleeping Beauty to genetically modify clinical-grade T cells to target CD19.

Authors:  Harjeet Singh; Helen Huls; Partow Kebriaei; Laurence J N Cooper
Journal:  Immunol Rev       Date:  2014-01       Impact factor: 12.988

9.  Detection and isolation of auto-reactive human antibodies from primary B cells.

Authors:  Victor G Sendra; Anthony Lie; Gabrielle Romain; Sandeep K Agarwal; Navin Varadarajan
Journal:  Methods       Date:  2013-06-26       Impact factor: 3.608

10.  Real time assays for quantifying cytotoxicity with single cell resolution.

Authors:  Sonny C Hsiao; Hong Liu; Taylor A Holstlaw; Cheng Liu; Catherine Y Francis; Matthew B Francis
Journal:  PLoS One       Date:  2013-06-24       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.